IWP
BIIB icon

Icon Wealth Partners’s Biogen BIIB Stock Holding History

Icon Wealth Partners’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$234K Sell
910
-17
-2% -$4.55K 0.03% 261
2023
Q2 		$264K Sell
927
-120
-11% -$35.7K 0.03% 276
2023
Q1 		$291K Buy
+1,047
New +$290K 0.03% 261
2022
Q2 		$277K Sell
1,356
-319
-19% -$65.2K 0.03% 256
2022
Q1 		$353K Buy
1,675
+11
+0.7% +$2.39K 0.04% 250
2021
Q4 		$399K Sell
1,664
-96
-5% -$24.7K 0.04% 232
2021
Q3 		$498K Sell
1,760
-233
-12% -$76.4K 0.05% 224
2021
Q2 		$690K Sell
1,993
-416
-17% -$126K 0.07% 197
2021
Q1 		$674K Buy
2,409
+371
+18% +$100K 0.08% 177
2020
Q4 		$499K Buy
2,038
+168
+9% +$43.3K 0.08% 178
2020
Q3 		$530K Buy
1,870
+269
+17% +$75K 0.1% 139
2020
Q2 		$428K Sell
1,601
-220
-12% -$66.1K 0.1% 141
2020
Q1 		$576K Sell
1,821
-327
-15% -$99.2K 0.23% 55
2019
Q4 		$637K Sell
2,148
-30
-1% -$8.32K 0.2% 60
2019
Q3 		$507K Buy
2,178
+4
+0.2% +$931 0.17% 66
2019
Q2 		$508K Buy
2,174
+625
+40% +$144K 0.18% 65
2019
Q1 		$366K Sell
1,549
-206
-12% -$64.9K 0.14% 88
2018
Q4 		$528K Sell
1,755
-41
-2% -$13.1K 0.25% 60
2018
Q3 		$635K Sell
1,796
-59
-3% -$20.3K 0.26% 61
2018
Q2 		$538K Buy
1,855
+292
+19% +$82.1K 0.23% 70
2018
Q1 		$428K Buy
1,563
+10
+0.6% +$3.1K 0.23% 94
2017
Q4 		$495K Buy
+1,553
New +$498K 0.25% 88

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Icon Wealth Partners's BIIB Position: Q3 2023 in Review

Icon Wealth Partners reduced its Biogen (BIIB) stake by 1.8% in Q3 2023, selling an estimated $4.55K and leaving 910 shares worth $234K. The position accounts for 0.03% of the portfolio, ranked #261.

Icon Wealth Partners first reported a position in BIIB in Q4 2017 and has held it in 22 quarters since. The position peaked at $690K in Q2 2021. 965 funds tracked by Wall St. Rank hold BIIB as of Q3 2023.

  • Icon Wealth Partners held 910 shares of Biogen worth $234K as of Q3 2023.
  • Icon Wealth Partners sold 17 Biogen shares in Q3 2023, an estimated $4.55K.
  • Biogen made up 0.03% of Icon Wealth Partners's portfolio in Q3 2023, its #261 holding.
  • Icon Wealth Partners first reported a position in Biogen in Q4 2017 and has held it in 22 quarters since.
  • Icon Wealth Partners's Biogen position peaked at $690K in Q2 2021.
  • 965 funds tracked by Wall St. Rank held Biogen as of Q3 2023.

Based on Icon Wealth Partners's 13F filing for Q3 2023, filed 14 Nov 2023.